Brief: Marinus Pharmaceuticals Reports Q4 And Full Year 2022 Financial Results

Marinus Pharmaceuticals

07/03/2023 21:07

March 7 (Reuters) - Marinus Pharmaceuticals Inc
 MRNS.O :
    * MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REPORTS
FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
    * MARINUS PHARMACEUTICALS INC SEES FOR FISCAL YEAR 2023,
ZTALMY
U.S. NET PRODUCT REVENUE OF BETWEEN $15 MILLION - $17 MILLION,
BARDA REVENUE BETWEEN $8 MILLION TO $11 MILLION
    * MARINUS PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE OF
COMMON
STOCK - BASIC AND DILUTED $0.76

Source text for Eikon:  ID:nBw5Q0dCDa 
Further company coverage:  MRNS.O 

 ((Reuters.Briefs@thomsonreuters.com;))